Evidence map›Paper›PMID 25296196›Full record

ArticlePloS one2014

Caenorhabditis elegans bacterial pathogen resistant bus-4 mutants produce altered mucins.

Lisa M Parsons, Rahman M Mizanur, Ewa Jankowska, Jonathan Hodgkin, Delia O Rourke, Dave Stroud, Salil Ghosh, John F Cipollo

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Exploring the mechanisms of host-specificity of a hyperparasitic bacterium (Frontiers in cellular and infection microbiology · 2023
    Review
  8. Journal of developmental biology · 2020
    Review
  9. Article
  10. Article
  11. Virulence · 2019
    Article
  12. Article
  13. Article
  14. N-glycomic Complexity in Anatomical Simplicity:Frontiers in molecular biosciences · 2019
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Lisa M ParsonsFood and Drug Administration, Center for Biologics Evaluation and Research, Bethesda, Maryland, United States of America.
Rahman M MizanurFood and Drug Administration, Center for Biologics Evaluation and Research, Bethesda, Maryland, United States of America.
Ewa JankowskaFood and Drug Administration, Center for Biologics Evaluation and Research, Bethesda, Maryland, United States of America.
Jonathan HodgkinGenetics Unit, Department of Biochemistry, University of Oxford, Oxford, United Kingdom.
Delia O RourkeGenetics Unit, Department of Biochemistry, University of Oxford, Oxford, United Kingdom.
Dave StroudGenetics Unit, Department of Biochemistry, University of Oxford, Oxford, United Kingdom.
Salil GhoshFood and Drug Administration, Center for Biologics Evaluation and Research, Bethesda, Maryland, United States of America.
John F CipolloFood and Drug Administration, Center for Biologics Evaluation and Research, Bethesda, Maryland, United States of America.
Center for Biologics Evaluation and Research · USUniversity of Oxford · GB

Funding

Medical Research Council G0600238Medical Research Council MR/J001309/1
6 · The paper itself

Abstract

Caenorabditis elegans bus-4 glycosyltransferase mutants are resistant to infection by Microbacterium nematophilum, Yersinia pestis and Yersinia pseudotuberculosis and have altered susceptibility to two Leucobacter species Verde1 and Verde2. Our objective in this study was to define the glycosylation changes leading to this phenotype to better understand how these changes lead to pathogen resistance. We performed MALDI-TOF MS, tandem MS and GC/MS experiments to reveal fine structural detail for the bus-4 N- and O-glycan pools. We observed dramatic changes in O-glycans and moderate ones in N-glycan pools compared to the parent strain. Ce core-I glycans, the nematode's mucin glycan equivalent, were doubled in abundance, halved in charge and bore shifts in terminal substitutions. The fucosyl O-glycans, Ce core-II and neutral fucosyl forms, were also increased in abundance as were fucosyl N-glycans. Quantitative expression analysis revealed that two mucins, let-653 and osm-8, were upregulated nearly 40 fold and also revealed was a dramatic increase in GDP-Man 4,6 dehydratease expression. We performed detailed lectin binding studies that showed changes in glycoconjugates in the surface coat, cuticle surface and intestine. The combined changes in cell surface glycoconjugate distribution, increased abundance and altered properties of mucin provide an environment where likely the above pathogens are not exposed to normal glycoconjugate dependent cues leading to barriers to these bacterial infections.

Indexed as

AnimalsBacteriaCaenorhabditis elegansCaenorhabditis elegans ProteinsGas Chromatography-Mass SpectrometryMucinsPolysaccharidesSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationCaenorhabditis elegans ProteinsMucinsPolysaccharides

Identifiers

PMID25296196
PMCPMC4189790
OpenAlexW1995295961

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.